PAUL WAKSMAN: Open Payments
NPI 1679034003 · SANDWICH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 24 payments from 15 companies in 2025. Trend: 2023 $1,534 · 2024 $114 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 2 | $90 |
| Zimmer Biomet Holdings, Inc. | 2 | $76 |
| ACCORD HEALTHCARE, INC. | 3 | $73 |
| Endo USA, Inc. | 2 | $68 |
| Ferring Pharmaceuticals Inc. | 3 | $67 |
| 180 Medical, Inc. | 2 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| Janssen Biotech, Inc. | 1 | $35 |
| TOLMAR, INC. | 1 | $30 |
| ABC Home Medical Supply, Inc. | 1 | $24 |
Products named: Camcevi, GENTLECATH, JELMYTO, GEMTESA, ZUSDURI, ADSTILADRIN, G7, AVEED.
Industry payments across MA — which companies pay providers there.
